In Vivo RNAi Screening Identifies a Leukemia-Specific Dependence on Integrin Beta 3 Signaling
Peter G. Miller(Brigham and Women's Hospital), Fátima Al‐Shahrour(Broad Institute), Kimberly A. Hartwell(Broad Institute), Lisa P. Chu(Brigham and Women's Hospital), Marcus Järås(Brigham and Women's Hospital), Rishi V. Puram(Brigham and Women's Hospital), Alexandre Puissant(Harvard University), Kevin P. Callahan(University of Rochester), John M. Ashton(University of Rochester), Marie McConkey(Brigham and Women's Hospital), Luke Poveromo(Brigham and Women's Hospital), Glenn S. Cowley(Broad Institute), Michael G. Kharas(Memorial Sloan Kettering Cancer Center), Myriam Labelle(Massachusetts Institute of Technology), Sebastian Shterental(Brigham and Women's Hospital), Joji Fujisaki(Massachusetts General Hospital), Lev Silberstein(Harvard University), Gabriela Alexe(Harvard University), Muhammad Al‐Hajj(GlaxoSmithKline (United States)), Christopher A. Shelton(GlaxoSmithKline (United States)), Scott A. Armstrong(Memorial Sloan Kettering Cancer Center), David E. Root(Broad Institute), David T. Scadden(Harvard University), Richard O. Hynes(Howard Hughes Medical Institute), Siddhartha Mukherjee(Cancer Research Center), Kimberly Stegmaier(Broad Institute), Craig T. Jordan(University of Rochester), Benjamin L. Ebert(Broad Institute)
Cited by 163Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis